Bangladesh have some 10 million patients with either Hepatitis B or C and about 40 million people suffering from fatty liver disease, experts said on Thursday.
But the costs of testing Hepatitis B and C viruses and the price of drugs for these infections were too high for common people in Bangladesh, they said at a conference at a Dhaka hotel.
Hepatology Society Dhaka, Bangladesh, organised the conference participated in by some 2,000 doctors of home and abroad.
The doctors also said awareness about Hepatitis A and E – which spread through contaminated food, water and human waste, were low in Bangladesh.
These patients recourse to alternative medicines as physicians usually do not prescribe any specific medicines for such patients, they said.
Speaking on the theme of the conference ‘Current Trends in the management of liver disorders in Bangladesh,’ liver expert Motahar Hossain said costs of investigations of Hepatitis B and C like HBV DNA and HCV RNA and drugs for those treatment were too high for common people in Bangladesh.
He said these tests should be made available at government hospitals at subsidised price.
Motahar said mass awareness about the spread of Hepatitis A and E was very low in Bangladesh.
‘Physicians usually don’t prescribe any specific medicines for such patients but the patients believe that the doctors cannot treat jaundice,’ he said.
‘These patients recourse to alternative medicines as physicians usually do not prescribe any specific medicines for such patients,’ he said.
The society general secretary Shahinul Islam said Bangladesh was encountering the changing landscape of liver disease.
He said the society’s studies in recent times found that there were some 40 million fatty liver patients and 10 million Hepatitis B and C patients in Bangladesh and to manage the huge number of such patients, Bangladesh needs a liver institute and 1,000 liver experts.
Want stories like this in your inbox?
Sign up to exclusive daily email
More Stories from Adults’ health